L-carnitine: Nutrition, pathology, and health benefits

被引:46
作者
Alhasaniah, Abdulaziz Hassan [1 ]
机构
[1] Najran Univ, Fac Appl Med Sci, Dept Clin Lab Sci, POB 1988, Najran 61441, Saudi Arabia
关键词
L; -carnitine; Nutrition; Pathology; Anti -wasting effect; Health benefits; ACETYL-L-CARNITINE; PROPIONYL-L-CARNITINE; ISCHEMIA-REPERFUSION INJURY; POLYCYSTIC-OVARY-SYNDROME; DIETARY L-CARNITINE; ALPHA-LIPOIC ACID; SKELETAL-MUSCLE; OXIDATIVE STRESS; IN-VITRO; CANCER-PATIENTS;
D O I
10.1016/j.sjbs.2022.103555
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Carnitine is a medically needful nutrient that contributes in the production of energy and the metabolism of fatty acids. Bioavailability is higher in vegetarians than in people who eat meat. Deficits in carnitine transporters occur as a result of genetic mutations or in combination with other illnesses such like hep-atic or renal disease. Carnitine deficit can arise in diseases such endocrine maladies, cardiomyopathy, dia-betes, malnutrition, aging, sepsis, and cirrhosis due to abnormalities in carnitine regulation. The exogenously provided molecule is obviously useful in people with primary carnitine deficits, which can be life-threatening, and also some secondary deficiencies, including such organic acidurias: by erad-icating hypotonia, muscle weakness, motor skills, and wasting are all improved L-carnitine (LC) have reported to improve myocardial functionality and metabolism in ischemic heart disease patients, as well as athletic performance in individuals with angina pectoris. Furthermore, although some intriguing data indicates that LC could be useful in a variety of conditions, including carnitine deficiency caused by long-term total parenteral supplementation or chronic hemodialysis, hyperlipidemias, and the prevention of anthracyclines and valproate-induced toxicity, such findings must be viewed with caution.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:18
相关论文
共 200 条
[1]   L-Carnitine decreases DNA damage and improves the in vitro blastocyst development rate in mouse embryos [J].
Abdelrazik, Hussein ;
Sharma, Rakesh ;
Mahfouz, Reda ;
Agarwal, Ashok .
FERTILITY AND STERILITY, 2009, 91 (02) :589-596
[2]  
Abdelrazik H, 2009, ARCH MED SCI, V5, pS43
[3]   L-Carnitine improves cognitive and renal functions in a rat model of chronic kidney disease [J].
Abu Ahmad, Nur ;
Armaly, Zaher ;
Berman, Sylvia ;
Jabour, Adel ;
Aga-Mizrachi, Shlomit ;
Mosenego-Ornan, Efrat ;
Avital, Avi .
PHYSIOLOGY & BEHAVIOR, 2016, 164 :182-188
[4]   Comparison of L-Carnitine and L-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH [J].
Acosta, Maria F. ;
Muralidhran, Priya ;
Abrahamson, Michael D. ;
Grijalva, Carissa L. ;
Carver, Megan ;
Tang, Haiyang ;
Klinger, Christina ;
Fineman, Jeffrey R. ;
Black, Stephen M. ;
Mansour, Heidi M. .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 65
[5]   Acetyl-L-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat [J].
Afshin-Majd, Siamak ;
Bashiri, Keyhan ;
Kiasalari, Zahra ;
Baluchnejadmojarad, Tourandokht ;
Sedaghat, Reza ;
Roghani, Mehrdad .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 :1-9
[6]  
Aliabadi E, 2012, IRAN J REPROD MED, V10, P77
[7]   Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats [J].
Aliev, Gjumrakch ;
Liu, Jiankang ;
Shenk, Justin C. ;
Fischbach, Kathryn ;
Pacheco, Gerardo J. ;
Chen, Shu G. ;
Obrenovich, Mark E. ;
Ward, Walter F. ;
Richardson, Arlan G. ;
Smith, Mark A. ;
Gasimov, Eldar ;
Perry, George ;
Ames, Bruce N. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (02) :320-333
[8]   Carnitine Inborn Errors of Metabolism [J].
Almannai, Mohammed ;
Alfadhel, Majid ;
El-Hattab, Ayman W. .
MOLECULES, 2019, 24 (18)
[9]   CLINICAL-VARIETIES OF CARNITINE AND CARNITINE PALMITOYLTRANSFERASE DEFICIENCY [J].
ANGELINI, C ;
TREVISAN, C ;
ISAYA, G ;
PEGOLO, G ;
VERGANI, L .
CLINICAL BIOCHEMISTRY, 1987, 20 (01) :1-7
[10]   Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients [J].
Argani, H ;
Rahbaninoubar, M ;
Ghorbanihagjo, A ;
Golmohammadi, Z ;
Rashtchizadeh, N .
NEPHRON CLINICAL PRACTICE, 2005, 101 (04) :C174-C179